Nils Martin Krantz
Chief Executive Officer presso SMART EYE AB
Patrimonio netto: 9 M $ in data 31/03/2024
Profilo
Nils Martin Krantz founded Smart Eye AB in 1999, where he is working as Chief Executive Officer from 1999.
Mr. Krantz also currently works at 1928diagnostics AB, as Director and Neoeye AB, as Director.
Mr. Krantz received his graduate degree from Chalmers University of Technology.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SMART EYE AB
3.11% | 30/06/2023 | 1 094 052 ( 3.11% ) | 9 M $ | 31/03/2024 |
Posizioni attive di Nils Martin Krantz
| Società | Posizione | Inizio |
|---|---|---|
| SMART EYE AB | Chief Executive Officer | 01/01/1999 |
Neoeye AB
 Neoeye AB Electronic Equipment/InstrumentsElectronic Technology Neoeye AB develops and designs sensor solutions for HMI applications. The private company is based in Stockholm, Sweden. | Director/Board Member | - |
1928diagnostics AB
 1928diagnostics AB Medical SpecialtiesHealth Technology 1928diagnostics AB develops diagnostic software solutions for bacterial infections. It delivers extended resistance profiles and bacterial identification. The firm replaced traditional bacterial culturing methods and develops a personalized medicine addressing to antibiotic resistance. The company was founded by Susanne Staaf and Kristina Lagerstedt in 2014 and is headquartered in Gothenburg, Sweden. | Director/Board Member | - |
Formazione di Nils Martin Krantz
| Chalmers University of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SMART EYE AB | Health Technology |
| Aziende private | 2 |
|---|---|
1928diagnostics AB
1928diagnostics AB Medical SpecialtiesHealth Technology 1928diagnostics AB develops diagnostic software solutions for bacterial infections. It delivers extended resistance profiles and bacterial identification. The firm replaced traditional bacterial culturing methods and develops a personalized medicine addressing to antibiotic resistance. The company was founded by Susanne Staaf and Kristina Lagerstedt in 2014 and is headquartered in Gothenburg, Sweden. | Health Technology |
Neoeye AB
Neoeye AB Electronic Equipment/InstrumentsElectronic Technology Neoeye AB develops and designs sensor solutions for HMI applications. The private company is based in Stockholm, Sweden. | Electronic Technology |
- Borsa valori
- Insiders
- Nils Martin Krantz
